These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 2928807

  • 1. A multicenter trial of cytarabine plus idarubicin or daunorubicin as induction therapy for adult nonlymphocytic leukemia.
    Wiernik PH, Case DC, Periman PO, Arlin ZA, Weitberg AB, Ritch PS, Todd MB.
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):25-9. PubMed ID: 2928807
    [No Abstract] [Full Text] [Related]

  • 2. Idarubicin plus cytarabine as first-line treatment of acute nonlymphoblastic leukemia.
    Lambertenghi-Deliliers G, Annaloro C, Cortelezzi A, Cortellaro M, Della Volpe A, Maiolo AT, Mozzana R, Pogliani E, Pozzoli E, Polli EE.
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):16-20. PubMed ID: 2928806
    [No Abstract] [Full Text] [Related]

  • 3. A phase-three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia.
    Vogler WR, Velez-Garcia E, Omura G, Raney M.
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):21-4. PubMed ID: 2648581
    [No Abstract] [Full Text] [Related]

  • 4. Idarubicin in acute leukemias: experience of the Italian Cooperative Group GIMEMA.
    Petti MC, Mandelli F.
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):10-5. PubMed ID: 2928805
    [No Abstract] [Full Text] [Related]

  • 5. Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center.
    Berman E, Raymond V, Gee T, Kempin SJ, Gulati S, Andreeff M, Kolitz J, Gabrilove J, Heller G, Young CW.
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):30-4. PubMed ID: 2928808
    [No Abstract] [Full Text] [Related]

  • 6. FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience.
    Candoni A, Simeone E, Tiribelli M, Malagola M, Russo D, Fanin R.
    Am J Hematol; 2009 Oct; 84(10):690-2. PubMed ID: 19731308
    [No Abstract] [Full Text] [Related]

  • 7. A phase II comparative study of idarubicin plus cytarabine versus daunorubicin plus cytarabine in adult acute myeloid leukemia.
    Masaoka T, Ogawa M, Yamada K, Kimura K, Ohashi Y.
    Semin Hematol; 1996 Oct; 33(4 Suppl 3):12-7. PubMed ID: 8916311
    [Abstract] [Full Text] [Related]

  • 8. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
    Liu Y, Ke XY, Ma J, Shen ZX, Zhang XH, Du X, Zhao YM, Lv JQ, Zhan ZM, Zeng XY, Xu XH, Lu ZS.
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381
    [Abstract] [Full Text] [Related]

  • 9. Idarubicin is superior to daunorubicin in remission induction of de novo acute myeloid leukemia patients with high MDR1 expression.
    Shi P, Zha J, Guo X, Chen F, Fan Z, Huang F, Meng F, Liu X, Feng R, Xu B.
    Pharmacogenomics; 2013 Jan; 14(1):17-23. PubMed ID: 23252945
    [Abstract] [Full Text] [Related]

  • 10. [Results of induction treatment with idarubicin for acute nonlymphoblastic leukemia in adults].
    Hołowiecki J, Krzemień S, Rudzka E, Krawczyk M, Wojnar J, Hołowiecka B, Wacławik A, Wojciechowska M, Kachel L, Cedrych I.
    Acta Haematol Pol; 1994 Jan; 25(3):221-30. PubMed ID: 7992594
    [Abstract] [Full Text] [Related]

  • 11. A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin (or other anthracyclines) as induction therapy for acute myeloid leukaemia. AML Collaborative Group.
    Br J Haematol; 1998 Oct; 103(1):100-9. PubMed ID: 9792296
    [Abstract] [Full Text] [Related]

  • 12. Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia.
    Wiernik PH, Banks PL, Case DC, Arlin ZA, Periman PO, Todd MB, Ritch PS, Enck RE, Weitberg AB.
    Blood; 1992 Jan 15; 79(2):313-9. PubMed ID: 1730080
    [Abstract] [Full Text] [Related]

  • 13. Risk-adapted induction and consolidation therapy in adults with de novo AML aged </= 60 years: results of a prospective multicenter trial.
    Heil G, Krauter J, Raghavachar A, Bergmann L, Hoelzer D, Fiedler W, Lübbert M, Noens L, Schlimok G, Arnold R, Kirchner H, Ganser A.
    Ann Hematol; 2004 Jun 15; 83(6):336-44. PubMed ID: 15034758
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Combination chemotherapy with DATV regimen in treatment of adult acute nonlymphocytic leukemia.
    Lou FD, Zhou Q, Liu HC, Meng FY, Wang YZ.
    Chin Med J (Engl); 1993 Nov 15; 106(11):876-8. PubMed ID: 8143502
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Idarubicin: an anthracycline antineoplastic agent.
    Cersosimo RJ.
    Clin Pharm; 1992 Feb 15; 11(2):152-67. PubMed ID: 1551297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.